SL
Sean Laaman Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
17
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Health Information Services
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $34 |
87%
upside
| 1 | +37% |
0
%
| 21 Nov ‘25 13 days ago |
|
|
|
Overweight
Maintained
| $45 |
1%
upside
| 3 | +0.82% |
0
%
| 5 Nov ‘25 29 days ago |
|
|
|
Overweight
Maintained
| $196 |
32%
upside
| 2 | +13% |
0
%
| 4 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $115 |
23%
upside
| 1 | +22% |
0
%
| 30 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $304 |
21%
upside
| 1 | -7.3% |
0
%
| 21 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $383 |
16%
upside
| 1 | +15% |
0
%
| 20 Oct ‘25 1 month ago |
|